parecoxib has been researched along with pituitrin in 1 studies
Studies (parecoxib) | Trials (parecoxib) | Recent Studies (post-2010) (parecoxib) | Studies (pituitrin) | Trials (pituitrin) | Recent Studies (post-2010) (pituitrin) |
---|---|---|---|---|---|
436 | 186 | 229 | 22,137 | 594 | 2,101 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bae, EH; Frøkiaer, J; Jensen, AM; Kim, SW; Nielsen, S; Nørregaard, R; Schweer, H; Wang, G | 1 |
1 other study(ies) available for parecoxib and pituitrin
Article | Year |
---|---|
Cyclooxygenase 2 inhibition exacerbates AQP2 and pAQP2 downregulation independently of V2 receptor abundance in the postobstructed kidney.
Topics: Adenylyl Cyclases; Animals; Aquaporin 2; Cyclooxygenase 2 Inhibitors; Down-Regulation; Isoxazoles; Kidney; Male; Phosphorylation; Rats; Rats, Sprague-Dawley; Receptors, Vasopressin; Reperfusion Injury; Sodium-Potassium-Chloride Symporters; Solute Carrier Family 12, Member 1; Vasopressins | 2010 |